Literature DB >> 18357388

ATR alterations in Hodgkin's lymphoma.

Angen Liu1, Tetsuya Takakuwa, Shigeki Fujita, Wen-Juan Luo, Kristianti Tresnasari, Anke Van den Berg, Sibrand Poppema, Katsuyuki Aozasa.   

Abstract

Hodgkin's lymphoma (HL) is characterized by the presence of neoplastic Hodgkin and Reed-Sternberg cells (HRSC) in a background of inflammatory cells. Free radicals and oxidative stress generated in the inflammatory lesions could cause DNA damage, thus providing a basis for lymphomagenesis. Ataxia-telangiectasia mutated (ATM) and Rad3-related (ATR) genes are responsive genes for DNA damage, therefore the potential involvement of the ATR gene in HL pathogenesis was examined in 8 HL cell lines and 7 clinical cases. ATR alterations were detected in 6 out of 8 HL lines. Most aberrant transcripts observed were heterozygous deletions, which may have resulted from aberrant splicing. ATR aberrant transcripts were also detected in 3 out of 7 clinical cases. Three alterations, del exon 4, deletion exon 29-34 and insertion of 137 bp in exon 46/47 were commonly observed in both cell lines and clinical samples. HL cells with ATR alterations except del exon 4 showed a delay/abrogation in repair for DNA double-strand breaks (DSBs) and single-strand break (SSB) as well as exhibiting a defect in p53 accumulation. These findings suggested the role of ATR gene alterations in HL lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18357388

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

Review 1.  Laser capture microdissection in the tissue biorepository.

Authors:  Angen Liu
Journal:  J Biomol Tech       Date:  2010-09

2.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008.

Authors:  J Han J M van Krieken
Journal:  J Hematop       Date:  2008-07       Impact factor: 0.196

3.  Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series.

Authors:  Anthony J Scott; Molly C Tokaz; Michelle F Jacobs; Arul M Chinnaiyan; Tycel J Phillips; Ryan A Wilcox
Journal:  Fam Cancer       Date:  2020-06-06       Impact factor: 2.375

Review 4.  RNA splicing: a new player in the DNA damage response.

Authors:  Silvia C Lenzken; Alessia Loffreda; Silvia M L Barabino
Journal:  Int J Cell Biol       Date:  2013-09-12

5.  A method for identifying discriminative isoform-specific peptides for clinical proteomics application.

Authors:  Fan Zhang; Jake Y Chen
Journal:  BMC Genomics       Date:  2016-08-22       Impact factor: 3.969

Review 6.  Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives.

Authors:  Corina Cuceu; William M Hempel; Laure Sabatier; Jacques Bosq; Patrice Carde; Radhia M'kacher
Journal:  Cancers (Basel)       Date:  2018-03-26       Impact factor: 6.639

7.  Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin's lymphoma.

Authors:  Chiara Mangano; Alberto Ferrarini; Claudio Forcato; Marianna Garonzi; Paola Tononi; Rossana Lanzellotto; Andrea Raspadori; Chiara Bolognesi; Genny Buson; Gianni Medoro; Michael Hummel; Francesca Fontana; Nicolò Manaresi
Journal:  Blood Cancer J       Date:  2019-11-21       Impact factor: 11.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.